A cross sectional study assessing differences between randomized clinical trial participants and real‐world empagliflozin users and to assess changes in HbA1c levels after empagliflozin initiation
Latest Information Update: 10 Dec 2020
At a glance
- Drugs Empagliflozin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Dec 2020 New trial record